Medicare Enrolled
Dr. Gregoire Bergier, MD
Hematology · Clearwater, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bergier from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bergier? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bergier
Dr. Gregoire Bergier is a hematology in Clearwater, FL, with 19 years in practice. Based on federal Medicare data, Dr. Bergier performed 107,766 Medicare services across 3,238 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bergier received a total of $7,232 from 55 pharmaceutical and/or device companies across 373 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bergier is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 42% volume in FL$ $7,232 industry payments
Medicare Practice Summary
Medicare Utilization ↗107,766
Medicare services
Top 42% in FL for hematology
3,238
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,672 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 35,190 | $0 | $4 |
| Filgrastim injection (Nivestym) for white blood cells | 19,260 | $0 | $1 |
| Iron sucrose injection (Venofer) | 13,100 | $0 | $5 |
| Anti-nausea injection (aprepitant) | 7,930 | $1 | $5 |
| Filgrastim injection (Zarxio) for white blood cells | 7,140 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia | 5,070 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 3,960 | $18 | $51 |
| Immune globulin infusion (Gammagard) | 3,518 | $36 | $108 |
| Dexamethasone injection (steroid) | 2,412 | $0 | $3 |
| Complete blood count (CBC) with differential | 1,934 | $8 | $29 |
| Blood draw (venipuncture) | 1,666 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 930 | $1 | $28 |
| Office visit, established patient (30-39 min) | 871 | $95 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 592 | $0 | $9 |
| Office visit, established patient (20-29 min) | 560 | $64 | $239 |
| Drug injection, under skin or into muscle | 499 | $11 | $69 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 395 | $22 | $84 |
| Administration of chemotherapy into vein, 1 hour or less | 307 | $96 | $378 |
| Injection, fluorouracil, 500 mg | 291 | $2 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 265 | $46 | $189 |
| Injection of additional new drug or substance into vein | 216 | $12 | $61 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 184 | $15 | $56 |
| Infusion into a vein for hydration, each additional hour | 137 | $10 | $42 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 137 | $1 | $6 |
| Injection, zoledronic acid, 1 mg | 137 | $7 | $69 |
| Injection, diphenhydramine hcl, up to 50 mg | 130 | $1 | $3 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 98 | $3 | $11 |
| Administration of chemotherapy into vein, each additional hour | 94 | $20 | $79 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 77 | $17 | $59 |
| Office visit, established patient, complex (40-54 min) | 70 | $131 | $474 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 70 | $1 | $7 |
| Infusion into a vein for hydration, 31-60 minutes | 69 | $25 | $156 |
| Administration of additional new drug or substance into vein, 1 hour or less | 69 | $49 | $178 |
| Infusion, normal saline solution , 1000 cc | 66 | $2 | $7 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 52 | $54 | $206 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 52 | $25 | $89 |
| Injection of drug or substance into vein | 43 | $28 | $156 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 42 | $130 | $637 |
| Automated urinalysis | 25 | $2 | $8 |
| Red blood count, automated test | 21 | $4 | $10 |
| Office visit, established patient (10-19 min) | 21 | $40 | $147 |
| New patient office visit (30-44 min) | 19 | $65 | $298 |
| Initial hospital admission, high complexity | 19 | $137 | $556 |
| New patient office visit (45-59 min) | 15 | $122 | $453 |
| New patient office visit, complex (60-74 min) | 13 | $146 | $585 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
37.1% high complexity
57.9% medium
5.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,232
Total received (2018-2024)
Avg $1,033/year across 7 years
Bottom 49% in FL for hematology
55
Companies
373
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,953 (96.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$279 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,275
2023$1,594
2022$522
2021$98
2020$290
2019$1,231
2018$1,221
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$774
Janssen Biotech, Inc.
$590
Celgene Corporation
$586
Gilead Sciences, Inc.
$442
E.R. Squibb & Sons, L.L.C.
$318
PFIZER INC.
$299
Lilly USA, LLC
$289
GENZYME CORPORATION
$282
Takeda Pharmaceuticals U.S.A., Inc.
$258
Daiichi Sankyo Inc.
$214
AstraZeneca Pharmaceuticals LP
$204
Merck Sharp & Dohme LLC
$201
Amgen Inc.
$189
ABBVIE INC.
$189
Genentech USA, Inc.
$172
Eisai Inc.
$156
Pharmacyclics LLC, An AbbVie Company
$127
Astellas Pharma US Inc
$125
Merck Sharp & Dohme Corporation
$111
Bayer Healthcare Pharmaceuticals Inc.
$110
Incyte Corporation
$109
Exelixis Inc.
$107
Ipsen Biopharmaceuticals, Inc
$101
ARRAY BIOPHARMA INC
$91
AbbVie, Inc.
$88
EMD Serono, Inc.
$86
SOBI, INC
$83
AbbVie Inc.
$82
Sun Pharmaceutical Industries Inc.
$74
Alexion Pharmaceuticals, Inc.
$72
Seagen Inc.
$70
Kite Pharma, Inc.
$60
Blueprint Medicines Corporation
$47
Boehringer Ingelheim Pharmaceuticals, Inc.
$42
Regeneron Healthcare Solutions, Inc.
$41
Pharmacosmos Therapeutics Inc.
$36
TAIHO ONCOLOGY, INC.
$33
GlaxoSmithKline, LLC.
$33
Dova Pharmaceuticals
$27
PharmaEssentia USA Corporation
$25
BeiGene USA, Inc.
$25
Taiho Oncology, Inc.
$25
SpringWorks Therapeutics, Inc.
$23
Stemline Therapeutics Inc.
$23
Aveo Pharmaceuticals, Inc.
$22
TESARO, Inc.
$20
Bayer HealthCare Pharmaceuticals Inc.
$20
MorphoSys, US Inc.
$19
AVEO Pharmaceuticals, Inc.
$19
Deciphera Pharmaceuticals Inc.
$18
JAZZ PHARMACEUTICALS INC.
$17
CSL Behring
$16
Kyowa Kirin, Inc.
$15
Helsinn Therapeutics (U.S.), Inc.
$14
Myriad Genetic Laboratories, Inc.
$14
Top 3 companies account for 27.0% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALUNBRIG · AYVAKIT · Abraxane · Afstyla · Alecensa · BESREMI · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CEREZYME · CYRAMZA · Cabometyx · Creon · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMEND · ENHERTU · EPKINLY · ERLEADA · Enhertu · FOTIVDA · FRUZAQLA · Fabhalta · GAUCHER-DISEASE · GILOTRIF · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · ODOMZO · OGSIVEO · ONUREG · OPDIVO · OPDUALAG · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · Padcev · Perjeta · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · SANDOSTATIN · SARCLISA · SCEMBLIX · SUTENT · Somatuline Depot · Stivarga · TASIGNA · TECENTRIQ · TECVAYLI · TUKYSA · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · XALKORI · XTANDI · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $7 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
41
Per 100K population
4.3
County median income
$70,293
Nearest hospital
MEASE COUNTRYSIDE HOSPITAL
2.8 mi
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bergier is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bergier experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Bergier performed 35,190 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bergier receive payments from pharmaceutical companies?
Yes. Dr. Bergier received a total of $7,232 from 55 companies across 373 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bergier's costs compare to other hematologys in Clearwater?
Dr. Bergier's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bergier) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Clearwater
Browse hematologys in Clearwater ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology